JP4298915B2 - 炎症疾患の予防および治療のための製剤 - Google Patents

炎症疾患の予防および治療のための製剤 Download PDF

Info

Publication number
JP4298915B2
JP4298915B2 JP2000523249A JP2000523249A JP4298915B2 JP 4298915 B2 JP4298915 B2 JP 4298915B2 JP 2000523249 A JP2000523249 A JP 2000523249A JP 2000523249 A JP2000523249 A JP 2000523249A JP 4298915 B2 JP4298915 B2 JP 4298915B2
Authority
JP
Japan
Prior art keywords
alkyl
group
poly
oxygen
oxidation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2000523249A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001525340A (ja
JP2001525340A5 (enExample
Inventor
ラブスキー，イーリイ
バツィク，イーリイ
ホーセィェク，パベル
Original Assignee
ウースタフ マクロモレクラルニー ケミエ アカデミエ ベド チェスケー リプブリキ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ウースタフ マクロモレクラルニー ケミエ アカデミエ ベド チェスケー リプブリキ filed Critical ウースタフ マクロモレクラルニー ケミエ アカデミエ ベド チェスケー リプブリキ
Publication of JP2001525340A publication Critical patent/JP2001525340A/ja
Publication of JP2001525340A5 publication Critical patent/JP2001525340A5/ja
Application granted granted Critical
Publication of JP4298915B2 publication Critical patent/JP4298915B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/0666—Polycondensates containing five-membered rings, condensed with other rings, with nitrogen atoms as the only ring hetero atoms
    • C08G73/0672—Polycondensates containing five-membered rings, condensed with other rings, with nitrogen atoms as the only ring hetero atoms with only one nitrogen atom in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0206—Polyalkylene(poly)amines
    • C08G73/0213—Preparatory process
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/0622—Polycondensates containing six-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms
    • C08G73/0627—Polycondensates containing six-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms with only one nitrogen atom in the ring
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/0622—Polycondensates containing six-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms
    • C08G73/0633—Polycondensates containing six-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms with only two nitrogen atoms in the ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Pyrrole Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
JP2000523249A 1997-12-03 1998-12-02 炎症疾患の予防および治療のための製剤 Expired - Lifetime JP4298915B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZ3867-97 1997-12-03
CZ19973867A CZ293419B6 (cs) 1997-12-03 1997-12-03 Přípravek k prevenci a hojení zánětlivých onemocnění
PCT/CZ1998/000046 WO1999028359A1 (en) 1997-12-03 1998-12-02 Preparation for prevention and healing of inflammation affections

Publications (3)

Publication Number Publication Date
JP2001525340A JP2001525340A (ja) 2001-12-11
JP2001525340A5 JP2001525340A5 (enExample) 2006-01-26
JP4298915B2 true JP4298915B2 (ja) 2009-07-22

Family

ID=5467367

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000523249A Expired - Lifetime JP4298915B2 (ja) 1997-12-03 1998-12-02 炎症疾患の予防および治療のための製剤

Country Status (9)

Country Link
US (1) US6610284B1 (enExample)
EP (1) EP1058698B1 (enExample)
JP (1) JP4298915B2 (enExample)
AU (1) AU1331399A (enExample)
CA (1) CA2312087C (enExample)
CZ (1) CZ293419B6 (enExample)
DE (1) DE69825319T2 (enExample)
SK (1) SK284875B6 (enExample)
WO (1) WO1999028359A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492521B2 (en) * 2000-11-03 2002-12-10 Cytec Technology Corp. Hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same
JP4506955B2 (ja) * 2004-07-07 2010-07-21 三菱瓦斯化学株式会社 安定ラジカルを持つ共重合体組成物の製造方法
EP1888658B1 (en) * 2005-06-08 2009-07-08 Ciba Holding Inc. Polymeric nitroxides their preparation and use
WO2011018472A2 (en) * 2009-08-14 2011-02-17 Basf Se Methods in cell cultures, and related inventions, employing certain additives
US8835000B2 (en) * 2011-12-23 2014-09-16 General Electric Company High-density fluorescent dye clusters
WO2014182713A1 (en) * 2013-05-06 2014-11-13 The Regents Of The University Of Minnesota Sugar free, statistical copolymers made from at least three monomers
CZ2014825A3 (cs) * 2014-11-28 2015-08-26 Ústav makromolekulární chemie AV ČR, v. v. i. Přípravek pro orální použití
US10660851B2 (en) 2015-01-02 2020-05-26 Rxos Medical Polyfunctional radical scavenger hydrogel formulation
CZ309768B6 (cs) * 2017-06-05 2023-09-27 Pharmacy point s.r.o Antibakteriální a antifungální hydrofilní gelová kompozice na bázi zesíťovaného kopolymeru 2-hydroxyethylmethakrylátu
CZ308284B6 (cs) * 2018-03-15 2020-04-15 Ústav makromolekulární chemie AV ČR, v. v. i. Přípravek na bázi interpenetrujících polymerních sítí pro hojení ran
EP3765084B1 (en) 2018-03-15 2021-09-15 Ustav Makromolekularni Chemie AV CR, V. V. I. Preparation based on interpenetrating polymer networks for wound healing
CN108863908B (zh) * 2018-04-24 2020-06-09 宿迁联盛科技股份有限公司 一种聚合型橡胶稳定剂中间体及其制备方法
CZ2018359A3 (cs) * 2018-07-17 2019-11-20 Ústav makromolekulární chemie AV ČR, v. v. i. Tekutý krycí přípravek pro ošetření ran
WO2020015768A1 (en) * 2018-07-17 2020-01-23 Ustav Makromolekularni Chemie Av Cr, V. V. I. Liquid wound dressing composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU76955A1 (enExample) * 1977-03-15 1978-10-18
US4987210A (en) * 1988-11-03 1991-01-22 Gaf Chemicals Corporation Polymerizable derivatives of 5-oxo-pyrrolidinecarboxylic acid
FR2695800B1 (fr) * 1992-09-23 1996-03-08 Inst Textile De France Compose antiseptique.
DE19630977A1 (de) * 1996-07-31 1998-02-05 Basf Ag Wasserlösliche Polymerisate und deren Verwendung in kosmetischen Formulierungen

Also Published As

Publication number Publication date
EP1058698B1 (en) 2004-07-28
CA2312087A1 (en) 1999-06-10
SK8232000A3 (en) 2001-02-12
JP2001525340A (ja) 2001-12-11
WO1999028359A1 (en) 1999-06-10
CZ293419B6 (cs) 2004-04-14
CA2312087C (en) 2010-05-04
AU1331399A (en) 1999-06-16
DE69825319T2 (de) 2005-07-14
US6610284B1 (en) 2003-08-26
EP1058698A1 (en) 2000-12-13
DE69825319D1 (de) 2004-09-02
CZ386797A3 (cs) 1999-06-16
SK284875B6 (sk) 2006-01-05

Similar Documents

Publication Publication Date Title
JP4298915B2 (ja) 炎症疾患の予防および治療のための製剤
ES2346201T3 (es) Hidrogel.
JP5543560B2 (ja) 感圧接着剤ヒドロゲルを製造する方法
EP0212959B1 (en) Sustained-release formulation containing an amin acid polymer with a lower alkyl (c1-c4) polar solvent
JP4681882B2 (ja) ポリ（オキシアルキレン）含有ポリマー材料の安定化
CN101280048B (zh) 具有抗菌作用的透明水凝胶及其制备方法
JP2004503624A (ja) ヒドロゲル組成物の製造方法ならびに前記製造方法によって製造されたヒドロゲル組成物
EP1063975A1 (en) Crosslinkable macromers bearing initiator groups
CN102548581A (zh) 粘合复合物凝聚层及其制备和使用方法
Ferreira et al. Photocrosslinkable polymers for biomedical applications
WO2023077699A1 (zh) 一种pH响应型水凝胶生物载体及应用
CN115010998B (zh) 一种抗菌抗氧化导电黏附水凝胶及其制备方法和应用
JP2000507298A (ja) Ｎ―ベンジル―ｎ―メチルアクリルアミドのポリマーおよびコポリマーから調製された高屈折率ヒドロゲル
Devi et al. Exploring bioactive tragacanth gum for developing nerve regenerating agent imprinted hydrogels for brain drug delivery
JP2009541532A (ja) ラクタム系ポリマー誘導体
JP2003505585A (ja) 親水性生体医学組成物
JP2004506688A (ja) 損傷、および他の適応症の治療
CN115487350B (zh) 一种调节免疫炎症微环境水凝胶支架及其制备方法和应用
KR101454597B1 (ko) 점막부착성 하이드로젤의 제조방법 및 이에 따라 제조된 점막부착성 하이드로젤
EP3824005B1 (en) Liquid wound dressing composition
JP7754443B2 (ja) 鎮痛材及びその製造方法
CA2963582C (en) Oral preparation comprising mucoadhesive, biocompatible hydrophilic polymer for preventing and/or treating inflammatory conditions of the gastrointestinal tract
CN112007208A (zh) 一种力致响应药物控释多功能伤口敷料及其制备方法与应用
JPH06306250A (ja) 作用物質含有高分子ゲル
JPH11246416A (ja) 点鼻用添加剤及び点鼻薬

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051201

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051201

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20071128

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20071221

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080115

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20080414

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20080423

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080714

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080812

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20081112

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081210

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20081216

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20081210

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090210

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090220

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090317

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090416

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120424

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130424

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140424

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term